Cargando...
The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
Chimeric antigen receptor T cell (CAR-T cell) therapy is a novel adoptive immunotherapy where T lymphocytes are engineered with synthetic receptors known as chimeric antigen receptors (CAR). The CAR-T cell is an effector T cell that recognizes and eliminates specific cancer cells, independent of maj...
Guardado en:
| Publicado en: | Acta Pharm Sin B |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6090008/ https://ncbi.nlm.nih.gov/pubmed/30109179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2018.03.001 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|